Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Arcellx, Inc.

ACLXNASDAQ
Healthcare
Biotechnology
$66.53
$0.00(0.00%)
U.S. Market is Open • 15:50

Arcellx, Inc. (ACLX) Stock Overview

Explore Arcellx, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.7B
P/E Ratio-16.70
EPS (TTM)$-3.93
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 Month$72.76
3 Months$50.06
1 Year Target$83.45

ACLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Arcellx, Inc. (ACLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $83.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.70 and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.64%
5-Day Change
-7.41%
1-Month Change
-11.17%
3-Month Change
-28.42%
6-Month Change
-10.35%
Year-to-Date (YTD) Change
1.22%
1-Year Change
-2.29%
3-Year Change
132.11%
5-Year Change
281.61%
All-Time (Max) Change
281.61%

Contact Information

240 327 0603
25 West Watkins Mill Road, Redwood City, MD, 20878

Company Facts

1,630 Employees
IPO DateFeb 4, 2022
CountryUS
Actively Trading

Frequently Asked Questions